TXNIP Regulates Peripheral Glucose Metabolism in Humans
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Type 2 diabetes mellitus (T2DM) is characterized by defects in insulin secretion and action. Impaired glucose uptake in skeletal muscle is believed to be one of the earliest features in the natural history of T2DM, although underlying mechanisms remain obscure. METHODS AND FINDINGS: We combined human insulin/glucose clamp physiological studies with genome-wide expression profiling to identify thioredoxin interacting protein (TXNIP) as a gene whose expression is powerfully suppressed by insulin yet stimulated by glucose. In healthy individuals, its expression was inversely correlated to total body measures of glucose uptake. Forced expression of TXNIP in cultured adipocytes significantly reduced glucose uptake, while silencing with RNA interference in adipocytes and in skeletal muscle enhanced glucose uptake, confirming that the gene product is also a regulator of glucose uptake. TXNIP expression is consistently elevated in the muscle of prediabetics and diabetics, although in a panel of 4,450 Scandinavian individuals, we found no evidence for association between common genetic variation in the TXNIP gene and T2DM. CONCLUSIONS: TXNIP regulates both insulin-dependent and insulin-independent pathways of glucose uptake in human skeletal muscle. Combined with recent studies that have implicated TXNIP in pancreatic beta-cell glucose toxicity, our data suggest that TXNIP might play a key role in defective glucose homeostasis preceding overt T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 TXNIP Expression in Individuals with Diabetes or at Risk for Developing Diabetes (A) TXNIP expression levels from individuals with NGT, IGT, or T2DM, using data from our previously published microarray study [18]. * p < 0.02; ** p < 0.01, Mann-Whitney U-test. (B) TXNIP expression levels from NGT individuals with family history of T2DM (FH+) or without (FH−), as well as individuals with T2DM, using data from a previously published microarray study [27]. * p < 0.03, Mann-Whitney U-test.](https://figures.cochat.ai/paper-figures/ca9ef16bc19d42259bbcc36f2b7c4340/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-2.jpg)

![Figure 4 Insulin-Mediated Glucose Uptake Versus TXNIP Expression This relationship is shown for individuals with NGT, IGT, and T2DM. Linear regression parameters are indicated for each of the groups. Data are from our previously published microarray study [18].](https://figures.cochat.ai/paper-figures/c969253506d74789b5b972b212cc68b2/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-4.jpg)

![Figure 6 Pattern of Genetic Variation at the TXNIP Locus Linkage disequilibrium between SNPs was analyzed using Haploview [55], and D′ values were calculated with 95% confidence intervals. D′ plot for each square depicts the magnitude of linkage disequilibrium for a pair of markers, red indicates high D′ with high logarithm of odds (LOD) score, while white indicates low D′ with low LOD score, and blue indicates high D′ with low LOD score.](https://figures.cochat.ai/paper-figures/1e45333953bb4d3999d14146d7c357ce/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-6.jpg)
![Figure 7 Model of TXNIP Regulation and Action and Its Potential Role in the Pathogenesis of T2DM (A) Previous studies have shown that glucose induces the expression of TXNIP in a variety of cells and tissues. In this study we show that insulin suppresses the expression of TXNIP. Moreover, we have found that forced expression of TXNIP results in reduced glucose uptake, while inhibition of TXNIP enhances glucose uptake. These results suggest that TXNIP serves as a glucose- and insulin-sensitive homeostatic switch that regulates glucose uptake in the periphery. (B) Role of TXNIP in glucose toxicity in the β-cell and in impaired glucose uptake in the periphery. Insulin deficiency or hyperglycemia can increase TXNIP levels in muscle, resulting in impaired peripheral glucose uptake. The pancreatic β-cell is initially able to compensate by secreting more insulin, but eventually the β-cell compensation fails. The resulting hyperglycemia may then elevate pancreatic β-cell TXNIP expression, which can induce apoptosis [40]. The loss of β-cells, in turn, results in decreased insulin production that further exacerbates peripheral IGT. The vicious cycle would eventually spiral to T2DM.](https://figures.cochat.ai/paper-figures/00021f5e308f4c0db15afac10c663543/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Parikh et al., 2007
In the citing paper
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Parikh et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“RNA Isolation, Target Preparation, and Hybridization RNA from skeletal muscle biopsies for studies A and B were extracted by the guadinium thiocyanate method [11].”
MethodHaploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525 · cited 1×
“Linkage disequilibrium between SNPs was analyzed using Haploview [55], and D9 values were calculated with 95% confidence intervals.”
MethodGolub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516 · cited 1×
“For study A, targets from human skeletal muscle biopsies [12] were hybridized to the Affymetrix HG-U133A GeneChip (http://www.”
MethodIn silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationBiochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764 · cited 1×
“To relate expression data with insulin-stimulated glucose uptake, a GEE model was used to adjust for the interdependence between twins [9,30].”
MethodBase-Calling of Automated Sequencer Traces Using Phred. I. Accuracy Assessment
Ewing, B., Hillier, L., Wendl, M. C., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.175 · Cited by 6,967 · cited 1×
“Each base was called using the PHRED software package [19,20], and quality scores were assigned.”
MethodBase-Calling of Automated Sequencer Traces Using Phred. II. Error Probabilities
Ewing, B., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.186 · Cited by 5,439 · cited 1×
“]. Genomic DNA was isolated from peripheral blood using standard procedures. We used specific primers (Applied Biosystems) to amplify the region by PCR. Sequencing was performed using Big Dye version 3.1 Cycle Sequencing kit (Applied Biosystems) according to the manufacturer's instructions, and separation was done on…”
MethodInfluentialCellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
Mc Causland, F. R., Brunelli, S. M., & Waikar, S. S. (2013) · American Journal of Nephrology · doi:10.1159/000355958 · Cited by 2,690
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · cited 2×
“Recent genomic studies have pointed to mitochondrial dysfunction and to ROS as possible culprits in the etiology of insulin resistance [18,27,47,48].”
BackgroundMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“Recent genomic studies have pointed to mitochondrial dysfunction and to ROS as possible culprits in the etiology of insulin resistance [18,27,47,48].”
BackgroundPurcell, S., Cherny, S. S., & Sham, P. C. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.1.149 · Cited by 2,057 · cited 1×
“3 and prevalence of diabetes of 8% [24].”
BackgroundPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952 · cited 3×
“Recent genomic studies have pointed to mitochondrial dysfunction and to ROS as possible culprits in the etiology of insulin resistance [18,27,47,48].”
BackgroundMethodEfficiency and power in genetic association studies
de Bakker, P. I. W., Yelensky, R., Pe'er, I., Gabriel, S. B., Daly, M. J., & Altshuler, D. (2005) · Nature Genetics · doi:10.1038/ng1669 · Cited by 1,688 · cited 1×
“We selected nine tag SNPs to capture all genotypes and haplotypes with r2 over 0.8 [ 22 ].”
MethodInfluentialSelf-citationPathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
The staden sequence analysis package
Staden, R. (1996) · Molecular Biotechnology · doi:10.1007/bf02900361 · Cited by 1,263 · cited 1×
“Sequence assembly and analysis were done using the Staden software package [21].”
MethodMartin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158 · cited 1×
“Of note, epidemiological studies have suggested roles for both insulin-dependent and insulin-independent pathways in the development of T2DM [4].”
BackgroundInsulin Action, Diabetogenes, and the Cause of Type II Diabetes
Kahn, C. R. (1994) · Diabetes · doi:10.2337/diab.43.8.1066 · Cited by 916
Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes Mellitus
Eriksson, J., Franssila-Kallunki, A., Ekstrand, A., Saloranta, C., Widén, E., Schalin, C., & Groop, L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210601 · Cited by 807
Self-citationPoitout, V., & Robertson, R. P. (2002) · Endocrinology · doi:10.1210/endo.143.2.8623 · Cited by 743 · cited 1×
“Hyperglycemia has long been known to exacerbate b-cell failure [52,53] and impaired skeletal muscle glucose uptake [54] via a process often termed glucose toxicity.”
BackgroundNishiyama, A., Matsui, M., Iwata, S., Hirota, K., Masutani, H., Nakamura, H., Takagi, Y., Sono, H., Gon, Y., & Yodoi, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21645 · Cited by 730 · cited 1×
“TXNIP was originally identified in a yeast two-hybrid screen for proteins that bind to thioredoxin, a protein that undergoes NADPHdependent reduction and has roles in cellular signaling and reactive oxygen species (ROS) metabolism [34].”
BackgroundVionnet, N., Hani, E. H., Dupont, S., Gallina, S., Francke, S., Dotte, S., De Matos, F., Durand, E., Leprêtre, F., Lecoeur, C., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316887 · Cited by 680 · cited 1×
“1, a region that has shown perhaps the most consistent linkage to T2DM [42,43].”
BackgroundThe BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells
Phan, R. T., & Dalla-Favera, R. (2004) · Nature · doi:10.1038/nature03147 · Cited by 679 · cited 1×
“G0S2 was recently shown to be a target gene of PPARa [31], while BCL6 is a proto-oncogene that suppresses p53 and is implicated in the pathogenesis of human B cell lymphoma [32].”
BackgroundFuruyama, T., Nakazawa, T., Nakano, I., & Mori, N. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490629 · Cited by 671
Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ
Lee, C.-H., Chawla, A., Urbiztondo, N., Liao, D., Boisvert, W. A., & Evans, R. M. (2003) · Science · doi:10.1126/science.1087344 · Cited by 580 · cited 1×
“BCL6 has also been reported to interact with PPARd [33].”
BackgroundCharacterization of a human preadipocyte cell strain with high capacity for adipose differentiation
Wabitsch, M., Brenner, R., Melzner, I., Braun, M., Möller, P., Heinze, E., Debatin, K.-M., & Hauner, H. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801520 · Cited by 562 · cited 1×
“Human Adipocyte Cell Culture Preadipocytes of human origin were obtained and passaged as previously described [13].”
MethodGroop, L., Forsblom, C., Lehtovirta, M., Tuomi, T., Karanko, S., Nissén, M., Ehrnström, B.-O., Forsén, B., Isomaa, B., Snickars, B., et al. (1996) · Diabetes · doi:10.2337/diab.45.11.1585 · Cited by 384 · cited 1×
“Although obesity is the most important risk factor for insulin resistance in the prediabetic state [5], other factors such as the toxic effects of elevated glucose (glucotoxicity) and lipids (lipotoxicity) also contribute to insulin resistance with progression of the disease [6].”
BackgroundSelf-citationSchulze, P. C., Yoshioka, J., Takahashi, T., He, Z., King, G. L., & Lee, R. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400549200 · Cited by 369 · cited 3×
“It is notable that whereas we identify TXNIP expression as being strongly repressed by insulin in vivo (Figure 1), many previous studies have identified TXNIP as being sharply induced by glucose in a variety of cell types, including pancreatic islets [35], fibroblasts [36], mesangial kidney cells [37], rat cardiomyocy…”
BackgroundResultSelf-citationLyssenko, V., Almgren, P., Anevski, D., Perfekt, R., Lahti, K., Nissén, M., Isomaa, B., Forsen, B., Homström, N., Saloranta, C., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.1.166 · Cited by 368 · cited 1×
“Impaired glucose uptake in muscle (both insulindependent and -independent) is believed to be one of the earliest features in the natural history of T2DM, and insulin resistance predicts future T2DM [2–4].”
BackgroundSelf-citationMinn, A. H., Hafele, C., & Shalev, A. (2005) · Endocrinology · doi:10.1210/en.2004-1378 · Cited by 367 · cited 3×
“Importantly, our findings, in combination with recent studies focused on the pancreatic b-cell [40], provide molecular insights into the pathogenesis of impaired insulin secretion and action (Figure 7B) that characterize the prediabetic state [1,51].”
BackgroundResultHirota, T., Okano, T., Kokame, K., Shirotani-Ikejima, H., Miyata, T., & Fukada, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206233200 · Cited by 317 · cited 1×
“It is notable that whereas we identify TXNIP expression as being strongly repressed by insulin in vivo (Figure 1), many previous studies have identified TXNIP as being sharply induced by glucose in a variety of cell types, including pancreatic islets [35], fibroblasts [36], mesangial kidney cells [37], rat cardiomyocy…”
ResultA genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians.
Elbein, S. C., Hoffman, M. D., Teng, K., Leppert, M. F., & Hasstedt, S. J. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1175 · Cited by 304 · cited 1×
“1, a region that has shown perhaps the most consistent linkage to T2DM [42,43].”
BackgroundLing, C., Poulsen, P., Carlsson, E., Ridderstråle, M., Almgren, P., Wojtaszewski, J., Beck-Nielsen, H., Groop, L., & Vaag, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21889 · Cited by 300 · cited 3×
“Resequencing of TXNIP We resequenced the TXNIP gene along with 2,200 bp upstream of the 59 end and 1,000 bp downstream of the 39 end in 48 individuals, 23 of whom showed expression of TXNIP in muscle in the highest quartile, while 25 had TXNIP expression in lowest quartile from our previous studies [9,18].”
MethodSelf-citationLife and Death of the Pancreatic β Cells
BONNERWEIR, S. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00305-2 · Cited by 277 · cited 1×
“Hyperglycemia has long been known to exacerbate b-cell failure [52,53] and impaired skeletal muscle glucose uptake [54] via a process often termed glucose toxicity.”
BackgroundHan, S. H., Jeon, J. H., Ju, H. R., Jung, U., Kim, K. Y., Yoo, H. S., Lee, Y. H., Song, K. S., Hwang, H. M., Na, Y. S., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206610 · Cited by 264 · cited 1×
“Second, we have observed an inverse correlation in the expression of TXNIP and mitochondrial oxidative phosphorylation (unpublished data), and previous studies have shown that TXNIP can serve as a transcriptional repressor [50].”
ResultEffects of filtering by Present call on analysis of microarray experiments
McClintick, J. N., & Edenberg, H. J. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-49 · Cited by 234 · cited 1×
“We included only those probe sets for which percentage present calls were greater than 50% of all scans to remove probe sets that were not reliably detected [25].”
BackgroundThe G0/G1 switch gene 2 is a novel PPAR target gene
Zandbergen, F., Mandard, S., Escher, P., Tan, N. S., Patsouris, D., Jatkoe, T., Rojas-Caro, S., Madore, S., Wahli, W., Tafuri, S., et al. (2005) · Biochemical Journal · doi:10.1042/bj20050636 · Cited by 228 · cited 1×
“G0S2 was recently shown to be a target gene of PPARa [31], while BCL6 is a proto-oncogene that suppresses p53 and is implicated in the pathogenesis of human B cell lymphoma [32].”
BackgroundShalev, A., Pise-Masison, C. A., Radonovich, M., Hoffmann, S. C., Hirshberg, B., Brady, J. N., & Harlan, D. M. (2002) · Endocrinology · doi:10.1210/en.2002-220564 · Cited by 219 · cited 1×
“as being sharply induced by glucose in a variety of cell types, including pancreatic islets [”
BackgroundAcquisition of increased hormone sensitivity during in vitro adipocyte development.
Rubin, C. S., Lai, E., & Rosen, O. M. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40427-3 · Cited by 217 · cited 1×
“3T3-L1 mouse fibroblasts (ATCC) were cultured in DMEM and differentiated by standard means [15], via media supplemented with 5 lg/ml insulin, 0.”
MethodWolfrum, C., Besser, D., Luca, E., & Stoffel, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1931483100 · Cited by 209 · cited 1×
“Because these forkhead family members are known to be excluded from the nucleus via Akt-mediated phosphorylation downstream of insulin signaling [41], and since TXNIP induction by glucose is blunted by the activation of the phosphatidylinositol-3-kinase/Akt pathway [38], this class of transcription factors represent e…”
BackgroundPoulsen, P., Levin, K., Petersen, I., Christensen, K., Beck-Nielsen, H., & Vaag, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.275 · Cited by 166 · cited 4×
“The clamp protocol for studies A and C (Figure S1) involved a 2-h hyperinsulinemic euglycemic clamp preceded by a 30-min intravenous glucose tolerance test (IVGTT) to determine first-phase insulin secretion as previously described [10].”
MethodInfluentialSelf-citationYechoor, V. K., Patti, M.-E., Saccone, R., & Kahn, C. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142301999 · Cited by 156 · cited 1×
“Insulin Receptor Signaling To determine whether the suppression of TXNIP by insulin in vivo is simply secondary to a decrease in circulating glucose, or due to a direct effect of insulin signaling, we examined Txnip gene expression using published microarray data from mice with disrupted insulin receptor signaling [28…”
BackgroundRoden, M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803102 · Cited by 149 · cited 1×
“Although obesity is the most important risk factor for insulin resistance in the prediabetic state [5], other factors such as the toxic effects of elevated glucose (glucotoxicity) and lipids (lipotoxicity) also contribute to insulin resistance with progression of the disease [6].”
BackgroundAl‐Khalili, L., Chibalin, A., Kannisto, K., Zhang, B. B., Permert, J., Holman, G. D., Ehrenborg, E., Ding, V. D. H., Zierath, J. R., & Krook, A. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3001-3 · Cited by 144 · cited 2×
“Primary human satellite cells were isolated from muscle biopsies obtained from healthy human volunteers by trypsin digestion and were grown to confluent myoblasts and differentiated into myotubes as previously described in detail [14].”
MethodSelf-citationWang, Z., Rong, Y., Malone, M. H., Davis, M. C., Zhong, F., & Distelhorst, C. (2005) · Oncogene · doi:10.1038/sj.onc.1209218 · Cited by 115 · cited 1×
“First, TXNIP expression is induced by glucocorticoids [49] and by glucose, and TXNIP elevations can stimulate ROS production [38].”
BackgroundYoshioka, J., Schulze, P. C., Cupesi, M., Sylvan, J. D., MacGillivray, C., Gannon, J., Huang, H., & Lee, R. T. (2004) · Circulation · doi:10.1161/01.cir.0000129771.32215.44 · Cited by 114 · cited 1×
“Monoclonal antibodies were raised against full-length TXNIP as described previously [17], and antibodies to beta-actin were purchased from Sigma.”
MethodSelf-citationYechoor, V. K., Patti, M.-E., Ueki, K., Laustsen, P. G., Saccone, R., Rauniyar, R., & Kahn, C. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407574101 · Cited by 106 · cited 2×
“Insulin Receptor Signaling To determine whether the suppression of TXNIP by insulin in vivo is simply secondary to a decrease in circulating glucose, or due to a direct effect of insulin signaling, we examined Txnip gene expression using published microarray data from mice with disrupted insulin receptor signaling [28…”
BackgroundThioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition
Sheth, S. S., Castellani, L. W., Chari, S., Wagg, C., Thipphavong, C. K., Bodnar, J. S., Tontonoz, P., Attie, A. D., Lopaschuk, G. D., & Lusis, A. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400341-jlr200 · Cited by 105
Florez, J. C., Sjögren, M., Burtt, N., Orho-Melander, M., Schayer, S., Sun, M., Almgren, P., Lindblad, U., Tuomi, T., Gaudet, D., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3313 · Cited by 85 · cited 1×
“All case-control pairs were individually matched for sex, age, region of origin, and body mass index (BMI) as previously described [23].”
MethodSelf-citationEriksson, K., & Lindg�rde, F. (1990) · Diabetologia · doi:10.1007/bf00404139 · Cited by 83 · cited 1×
“Participants in all three studies underwent an oral glucose (75 g) tolerance test, and glucose tolerance was diagnosed according to the World Health Organization criteria [8].”
MethodVitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells
Kobayashi, T., Uehara, S., Ikeda, T., Itadani, H., & Kotani, H. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00263.x · Cited by 81 · cited 1×
“It is notable that whereas we identify TXNIP expression as being strongly repressed by insulin in vivo (Figure 1), many previous studies have identified TXNIP as being sharply induced by glucose in a variety of cell types, including pancreatic islets [35], fibroblasts [36], mesangial kidney cells [37], rat cardiomyocy…”
ResultDonnelly, K. L., Margosian, M. R., Parks, E. J., Sheth, S. S., & Lusis, A. J. (2004) · Journal of Nutrition · doi:10.1093/jn/134.6.1475 · Cited by 64 · cited 1×
“[44,45] and in b-cell glucose toxicity [35].”
The effect of hyperglycaemia on glucose disposal and insulin signal transduction in skeletal muscle
Zierath, J. R., & Kawano, Y. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(03)00040-x · Cited by 45 · cited 1×
“Hyperglycemia has long been known to exacerbate b-cell failure [52,53] and impaired skeletal muscle glucose uptake [54] via a process often termed glucose toxicity.”
BackgroundSelf-citationHansen, L., Gaster, M., Oakeley, E. J., Brusgaard, K., Nielsen, E.-M. D., Beck‐Nielsen, H., Pedersen, O. B., & Hemmings, B. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.146 · Cited by 45 · cited 1×
“First, we analyzed microarray data from a published study that profiled human primary cultured myotubes following insulin treatment [39].”
MethodAl‐Khalili, L., Cartee, G. D., & Krook, A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01124-0 · Cited by 39 · cited 1×
“On day 2 of differentiation, cells were transfected as described previously [16] with short interfering RNA (siRNA) directed against TXNIP (Dharmacon, http://www.”
MethodSelf-citation
Research works printed but not linked: 56
- Kahn, 1994, Diabetes, 43, 1066
- Eriksson, 1989, N Engl J Med, 321, 337
- Lyssenko, 2005, Diabetes, 54, 166
- Martin, 1992, Lancet, 340, 925
- Groop, 1996, Diabetes, 45, 1585
- Roden, 2005, Int J Obes, 2, S111
- Shulman, 2000, J Clin Invest, 106, 171
- Eriksson, 1990, Diabetologia, 33, 526
- Ling, 2004, J Clin Invest, 114, 1518
- Poulsen, 2005, Diabetes, 54, 275
- Chomczynski, 1987, Anal Biochem, 162, 156
- Golub, 1999, Science, 286, 531
- Wabitsch, 2001, Int J Obes Relat Metab Disord, 25, 8
- Al-Khalili, 2003, Cell Mol Life Sci, 60, 991
- Rubin, 1977, J Biol Chem, 252, 3554
- Al-Khalili, 2003, Biochem Biophys Res Commun, 307, 127
- Yoshioka, 2004, Circulation, 109, 2581
- Mootha, 2003, Nat Genet, 34, 267
- Ewing, 1998, Genome Res, 8, 186
- Ewing, 1998, Genome Res, 8, 175
- Staden, 1996, Mol Biotechnol, 5, 233
- de Bakker, 2005, Nat Genet, 37, 1217
- Florez, 2004, Diabetes, 53, 3313
- Purcell, 2003, Bioinformatics, 19, 149
- McClintick, 2006, BMC Bioinformatics, 7, 49
- Tusher, 2001, Proc Natl Acad Sci U S A, 98, 5116
- Patti, 2003, Proc Natl Acad Sci U S A, 100, 8466
- Yechoor, 2002, Proc Natl Acad Sci U S A, 99, 10587
- Yechoor, 2004, Proc Natl Acad Sci U S A, 101, 16525
- Zeger, 1986, Biometrics, 42, 121
- Zandbergen, 2005, Biochem J, 392, 313
- Phan, 2004, Nature, 432, 635
- Lee, 2003, Science, 302, 453
- Nishiyama, 1999, J Biol Chem, 274, 21645
- Shalev, 2002, Endocrinology, 143, 3695
- Hirota, 2002, J Biol Chem, 277, 44244
- Kobayashi, 2003, Kidney Int, 64, 1632
- Schulze, 2004, J Biol Chem, 279, 30369
- Hansen, 2004, Biochem Biophys Res Commun, 323, 685
- Minn, 2005, Endocrinology, 146, 2397
- Wolfrum, 2003, Proc Natl Acad Sci U S A, 100, 11624
- Elbein, 1999, Diabetes, 48, 1175
- Vionnet, 2000, Am J Hum Genet, 67, 1470
- Donnelly, 2004, J Nutr, 134, 1475
- Sheth, 2005, J Lipid Res, 46, 123
- Brownlee, 2001, Nature, 414, 813
- Houstis, 2006, Nature, 440, 944
- Petersen, 2003, Science, 300, 1140
- Wang, 2006, Oncogene, 25, 1903
- Han, 2003, Oncogene, 22, 4035
- DeFronzo, 2004, Med Clin North Am, 88
- Bonner-Weir, 2000, Trends Endocrinol Metab, 11, 375
- Poitout, 2002, Endocrinology, 143, 339
- Zierath, 2003, Best Pract Res Clin Endocrinol Metab, 17, 385
- Barrett, 2005, Bioinformatics, 21, 263
- Furuyama, 2000, Biochem J, 349, 629
Cited by
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
“Moreover, the NLRP3-binding protein, TXNIP, is itself heavily implicated in T2D, as a mediator of pancreatic b cell death and failing peripheral glucose uptake (Parikh et al., 2007; Shalev, 2008).”
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
“In beta cells, TXNIP is downregulated by insulin, and TXNIP expression is consistently higher in humans with type 2 diabete”
BackgroundThe PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism
Hoxhaj, G., & Manning, B. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0216-7 · Cited by 2,137
The thioredoxin antioxidant system
Lu, J., & Holmgren, A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.036 · Cited by 2,055
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990
Metadata
- Authors
- Parikh, H., Carlsson, E., Chutkow, W. A., Johansson, L. E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P. C., Mazzini, M. J., Jensen, C. B., Krook, A., Björnholm, M., Tornqvist, H., Zierath, J. R., Ridderstråle, M., Altshuler, D., Lee, R. T., Vaag, A., Groop, L. C., & Mootha, V. K.
- Affiliations
- Lund University (SE)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Karolinska Institutet (SE)
- Novo Nordisk (Denmark) (DK)
- University of Helsinki (FI)
- Corresponding author
- Groop, Leif C
- Mootha, Vamsi K
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-05-01
- Volume
- 4
- Issue
- 5
- Pages
- e158
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC1858708
- OpenAlex
- W2158951820
- Cited by
- 495
- References
- 57
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 24 · 2023: 41 · 2022: 35 · 2021: 39 · 2020: 34 · 2019: 22 · 2018: 29 · 2017: 21 · 2016: 29 · 2015: 29 · 2014: 23 · 2013: 28 · 2012: 31
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- American Diabetes Association
- Burroughs Wellcome Fund
- Richard and Susan Smith Family Foundation
- European Commission
- Karolinska Institutet
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- TXNIP, type 2 diabetes, skeletal muscle glucose uptake, peripheral glucose metabolism, insulin signaling, adipocytes, prediabetes, glucose homeostasis, insulin-independent glucose uptake, genetic association
- MeSH terms
- Animals, Blood Glucose, Carrier Proteins, Cells, Cultured, Diabetes Mellitus, Type 2, DNA-Binding Proteins, Gene Expression Regulation, Homeostasis, Humans, Hypoglycemic Agents, Insulin, Promoter Regions, Genetic, Glucose Clamp Technique, Linkage Disequilibrium, Polymerase Chain Reaction, Adipocytes, Glucose Intolerance, Muscle, Skeletal, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Protein Array Analysis, Qb-SNARE Proteins, Proto-Oncogene Proteins c-bcl-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.